<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00108342</url>
  </required_header>
  <id_info>
    <org_study_id>NEUA-015-07S</org_study_id>
    <nct_id>NCT00108342</nct_id>
    <nct_alias>NCT00876239</nct_alias>
  </id_info>
  <brief_title>Nicotine Delivery Systems: Research &amp; Treatment</brief_title>
  <acronym>NDS</acronym>
  <official_title>Nicotine Delivery Systems: Research and Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether sampling nicotine replacement treatments
      (NRTs) is superior to learning about them by computer. Testing also covers preferences among
      the treatments. Subjects will be enrolled veterans who smoke.

      Hypothesis: Direct experience (&quot;sampling&quot;) of NRTs will increase knowledge about NRTs,
      motivation/confidence, use of NRTs and quit attempts in contrast to learning about NRTs by
      computer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was designed to compare sampling of several nicotine replacement treatments (NRTs)
      in contrast to a computer learning control. The NRTs include: 2 dosages of nicotine gum, 2
      dosages of nicotine lozenges and 2 dosages of oral nicotine inhalers. In the sampling group,
      each participant tries each of the 6 NRTs for 3 minutes. In the control, the individuals read
      about the treatments. Dependent measures include: quit attempts, use of NRTs, preferences
      among NRTs, and learning and motivation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Common comorbidities of Veterans precluded sufficient recruitment and enrollment.
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quit Attempts, Use of NRTs, Preference Among NRTs</measure>
    <time_frame>At testing, at follow-up</time_frame>
    <description>In addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>Nicotine Replacement Treatment (NRT) Sampling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sampling = 3 minute testing of each of 6 NRTs (3 forms x 2 dosages)
2 mg and 4 mg nicotine gum; 2 mg and 4 mg nicotine lozenges; frequent and infrequent puffing on a nicotine inhaler (can yield 4 mg from 10 mg device).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NRT Computer Learning</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine gum - 2 mg and 4 mg</intervention_name>
    <arm_group_label>Nicotine Replacement Treatment (NRT) Sampling</arm_group_label>
    <other_name>Nicorette gum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine lozenges - 2 mg and 4 mg</intervention_name>
    <arm_group_label>Nicotine Replacement Treatment (NRT) Sampling</arm_group_label>
    <other_name>Nicorette Commit lozenges</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine inhaler (4 mg yield) - low and high &quot;dosage&quot; by frequency of puffing</intervention_name>
    <description>can yield 4 mg from 10 mg device - infrequent and frequent puffing</description>
    <arm_group_label>Nicotine Replacement Treatment (NRT) Sampling</arm_group_label>
    <other_name>Nicotrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computer learning</intervention_name>
    <arm_group_label>NRT Computer Learning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be enrolled veteran who smokes.

        Exclusion Criteria:

          -  Any event or condition that could be exacerbated by the local effects of nicotine
             treatments (e.g., throat or stomach problems; any kind of wheezing from a condition or
             medication)

          -  other criteria as determined by PI and study physicians

          -  reactions to menthol (inhaler) or to aspartame (lozenge)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina G. Schneider, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System, West LA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West LA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2005</study_first_submitted>
  <study_first_submitted_qc>April 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2005</study_first_posted>
  <results_first_submitted>December 19, 2013</results_first_submitted>
  <results_first_submitted_qc>June 2, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 4, 2014</results_first_posted>
  <last_update_submitted>June 2, 2014</last_update_submitted>
  <last_update_submitted_qc>June 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nicotine</keyword>
  <keyword>drug therapy</keyword>
  <keyword>Smoking Cessation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>25 enrollees gave their signed consent and were then screened for participation; a total of 17 participated in testing.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>NRT Sampling</title>
          <description>Sampling = actual 3 minute testing of each of 6 NRTs (3 forms x 2 dosages)
Nicotine gum - 2 mg and 4 mg
Nicotine lozenges - 2 mg and 4 mg
Nicotine inhaler - infrequent and frequent puffing for dosage (can yield 4 mg from 10 mg device)</description>
        </group>
        <group group_id="P2">
          <title>NRT Computer Learning</title>
          <description>Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NRT Sampling</title>
          <description>Sampling = actual 3 minute testing of each of 6 NRTs (3 forms x 2 dosages)
Nicotine gum - 2 mg and 4 mg
Nicotine lozenges - 2 mg and 4 mg
Nicotine inhaler - infrequent and frequent puffing for dosage (can yield 4 mg from 10 mg device)</description>
        </group>
        <group group_id="B2">
          <title>NRT Computer Learning</title>
          <description>Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quit Attempts, Use of NRTs, Preference Among NRTs</title>
        <description>In addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.</description>
        <time_frame>At testing, at follow-up</time_frame>
        <population>The study was terminated and the data were not analyzed due to the small sample size.</population>
        <group_list>
          <group group_id="O1">
            <title>NRT Sampling</title>
            <description>Sampling = actual 3 minute testing of each of 6 NRTs (3 forms x 2 dosages)
Nicotine gum - 2 mg and 4 mg
Nicotine lozenges - 2 mg and 4 mg
Nicotine inhaler - infrequent and frequent puffing for dosage (can yield 4 mg from 10 mg device)</description>
          </group>
          <group group_id="O2">
            <title>NRT Computer Learning</title>
            <description>Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only</description>
          </group>
        </group_list>
        <measure>
          <title>Quit Attempts, Use of NRTs, Preference Among NRTs</title>
          <description>In addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.</description>
          <population>The study was terminated and the data were not analyzed due to the small sample size.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Assessment of adverse events was carried out by the PI, a Study Physician, and a Research Assistant. In this study, a non-serious adverse event was one that involved expected side effects of the medications. These were monitored for the NRT Sampling Arm during testing. Side effects were not assessed for the Computer Learning intervention.</desc>
      <group_list>
        <group group_id="E1">
          <title>NRT Sampling</title>
          <description>Sampling = actual 3 minute testing of each of 6 NRTs (3 forms x 2 dosages)
Nicotine gum - 2 mg and 4 mg
Nicotine lozenges - 2 mg and 4 mg
Nicotine inhaler - infrequent and frequent puffing for dosage (can yield 4 mg from 10 mg device)</description>
        </group>
        <group group_id="E2">
          <title>NRT Computer Learning</title>
          <description>Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea or Light-Headedness</sub_title>
                <description>Side effects, for the non-serious events (light-headedness, nausea) were anticipated events and resolved quickly.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations of the study: early termination of the study occurred due to widespread comorbidities precluding recruitment and enrollment of Veterans in this NRT trial. Specifically, the sample size was too small for any data analyses.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Nina G. Schneider, Ph.D., Principle Investigator</name_or_title>
      <organization>Department of Veterans Affairs - VAGLA</organization>
      <phone>310-268-3059</phone>
      <email>ngs@ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

